Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription 16.03.2026 1 Clin Exp Immunol 2 Clin Infect Dis 1 Dig Dis Sci 2 Gut 1 Hepatology 1 J Clin Gastroenterol 3 J Hepatol 2 J Med Virol 4 J Viral Hepat 3 PLoS One 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Exp Immunol

1. HALLIDAY N, Kennedy A, Williams C, Soskic B, et al
   An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis.
   Clin Exp Immunol. 2026 Mar 11:uxag013. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. FURUKAWA NW, Kamili S, Wester C
   A Turning Point for Hepatitis C Care: Point-of-Care HCV RNA Authorization as a Critical First Step Towards Integrated Test-and-Treat Models in the United States.
   Clin Infect Dis. 2026 Mar 13:ciag174. doi: 10.1093.
   PubMed        
   
   
3. HAVENS JR, Fluker SA, Schimmel J, McCrary LM, et al
   Performance Evaluation of the Xpert(R) HCV test on Fingerstick Blood in a Prospective Observational Clinical Study at CLIA-Waived Sites in the United States.
   Clin Infect Dis. 2026 Mar 13:ciag173. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

4. KANT R, Penugurti V, Manne RK
   Core Values: Does Clusterin Functionally Link HCV Core Protein Signaling to Malignant Phenotypes in HCV-Associated HCC?
   Dig Dis Sci. 2026 Mar 10. doi: 10.1007/s10620-026-09814.
   PubMed        
   
   

   
   Gut

5. PARLATI L, Bourliere M
   Steatosis severity and metabolic fingerprints after HCV eradication: toward an individualised approach to HCC surveillance after HCV cure.
   Gut. 2026 Mar 11:gutjnl-2026-338140. doi: 10.1136/gutjnl-2026-338140.
   PubMed        
   
   
6. HU J, Liu T, Klohn M, Freistaedter A, et al
   Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models.
   Gut. 2026 Mar 6:gutjnl-2025-336714. doi: 10.1136/gutjnl-2025-336714.
   PubMed         Abstract available
   
   

   
   Hepatology

7. RAHMAN SA, Gangadhara S, Gridley J, Mala U, et al
   T and B cell targeting DNA/MVA HCV vaccines induce strong and broad cellular and humoral immunity in mice and rhesus macaques.
   Hepatology. 2026 Mar 6. doi: 10.1097/HEP.0000000000001732.
   PubMed         Abstract available
   
   

   
   J Clin Gastroenterol

8. SHETTY A, Ibrahim B, Eskander B, Saab S, et al
   Management of Patients After Treatment of Severe Alcohol-associated Hepatitis.
   J Clin Gastroenterol. 2023;57:991-1000.
   PubMed         Abstract available
   
   

   
   J Hepatol

9. LEMPP FA, Volz T, Cameroni E, Benigni F, et al
   Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
   J Hepatol. 2023;79:1129-1138.
   PubMed         Abstract available
   
   
10. ZHANG Y, Tan W, Wang X, Zheng X, et al
    Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes.
    J Hepatol. 2023;79:1159-1171.
    PubMed         Abstract available
    
    
11. GANE EJ, Kim W, Lim TH, Tangkijvanich P, et al
    First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection.
    J Hepatol. 2023;79:1139-1149.
    PubMed         Abstract available
    
    

    
    J Med Virol

12. ZENG W, Wang J, Liang X, Hou J, et al
    A Genetic Variant of TLR6 Predicts HBsAg Decline After Pegylated Interferon-Alpha Treatment in HBeAg-Positive Chronic Hepatitis B.
    J Med Virol. 2026;98:e70872.
    PubMed         Abstract available
    
    
13. XU H, Yang X, Chen L, Yao X, et al
    Evaluation of HBsAg and Anti-HBs Coexistence: Authenticity and Contributing Factors.
    J Med Virol. 2026;98:e70862.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

14. SHAH S, Mafirakureva N, Trickey A, Hasnain A, et al
    Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan.
    J Viral Hepat. 2026;33:e70164.
    PubMed         Abstract available
    
    
15. SHIBLI S, Suki M, Korzom T, Green MS, et al
    Hepatitis B Vaccine Response in Children of Vaccinated Versus Unvaccinated Mothers: A Retrospective Cohort Study.
    J Viral Hepat. 2026;33:e70165.
    PubMed         Abstract available
    
    
16. XU J, Cao Y, Xiao Y, Li W, et al
    A New Model for Hepatitis C Elimination: CDC-Dispatching Follow-Up Coordinators Stationed in Hospitals.
    J Viral Hepat. 2026;33:e70163.
    PubMed         Abstract available
    
    
17. FRAGA M, Kasmi S, Weber SN, Liebe R, et al
    Prolonged Intrahepatic Cholestasis After Acute Hepatitis E Infection: A Case Series and Genetic Analysis.
    J Viral Hepat. 2026;33:e70156.
    PubMed         Abstract available
    
    

    
    PLoS One

18. MORETTI G, Tramonti Fantozzi MP, Corazza I, De Vita E, et al
    Clinical outcomes and patient-reported measures in HCV care: Insight from a longitudinal prospective study in a large Italian region.
    PLoS One. 2026;21:e0343936.
    PubMed         Abstract available
    
    
19. MEZIERE L, Fieulaine S, Montpellier C, Ferrie M, et al
    Functional study of two flexible regions of the hepatitis E virus ORF1 replicase.
    PLoS One. 2026;21:e0343555.
    PubMed         Abstract available
    
    
20. WORKNEH YA, Sisay DM, Fekadu A, Bika AT, et al
    In silico design of novel recombinant antigens containing immunologically relevant regions of wild-type and escape mutant variants of HBsAg.
    PLoS One. 2026;21:e0344362.
    PubMed         Abstract available
    
    

    
    Transplant Proc

21. BARZOLA E, Marin-Gomez L, Laga I, Padillo-Ruiz J, et al
    Emergency Deceased Donor Liver Transplantation Using a PTFE Graft for Complex Arterial Reconstruction: A Technical Note.
    Transplant Proc. 2026 Feb 5:S0041-1345(26)00058.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum